Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative.
Subacute cutaneous lupus erythematosus (SCLE) is a common manifestation of systemic lupus erythematosus. In many cases it appears to be resistant to various systemic or topical treatments. Three cases of resistant SCLE with good response to intravenous immunoglobulin (IVIG) are described here suggesting that IVIG could be an alternative treatment in these patients.
Lampropoulos
Christos E
CE
The Louise Coote Lupus Unit, The Rayne Institute, St. Thomas' Hospital, 4 Lambeth Palace Road, London, SE1 7EH, UK.
Hughes
Graham R V
GR
D' Cruz
David P
DP